Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,942 | 34,912 | 11,666 | 41,262 | 31,220 |
| Marketable Securities | N/A | 0 | 20,472 | N/A | N/A |
| Receivables | 68 | 15 | 521 | 866 | 90 |
| Other current assets | 980 | 0 | 0 | 0 | 0 |
| TOTAL | $18,875 | $38,173 | $35,684 | $44,904 | $33,736 |
| Non-Current Assets | |||||
| PPE Net | 1,312 | 647 | 652 | 976 | 609 |
| Other Non-Current Assets | 0 | 0 | 998 | 0 | 0 |
| TOTAL | $1,312 | $647 | $1,650 | $976 | $609 |
| Total Assets | $20,187 | $38,820 | $37,334 | $45,880 | $34,346 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,087 | 1,082 | 2,252 | N/A | N/A |
| Accrued Expenses | 3,705 | 2,490 | 1,398 | N/A | N/A |
| Other current liabilities | 1,618 | 532 | 79 | 408 | 655 |
| TOTAL | $6,687 | $4,237 | $3,945 | $2,690 | $2,709 |
| Non-Current Liabilities | |||||
| TOTAL | $7,517 | $7,020 | $6,887 | $7,091 | $6,883 |
| Total Liabilities | $14,204 | $11,257 | $10,832 | $9,781 | $9,593 |
| Shareholders' Equity | |||||
| Common Shares | 438,193 | 430,906 | 404,040 | 391,348 | 356,824 |
| Retained earnings | -477,713 | -446,003 | -418,251 | -393,416 | -367,111 |
| Other shareholders' equity | 961 | 544 | 662 | 4,005 | 4,018 |
| TOTAL | $5,983 | $27,563 | $26,502 | $36,099 | $24,753 |
| Total Liabilities And Equity | $20,187 | $38,820 | $37,334 | $45,880 | $34,346 |